Chronic inflammation and wound healing1 Cellular components - PowerPoint PPT Presentation

1 / 65
About This Presentation
Title:

Chronic inflammation and wound healing1 Cellular components

Description:

Chronic inflammation and wound healing1. Cellular components. WWAMI lecture. Nicole Meissner-Pearson ... Nicole Meissner-Pearson. Mechanisms of Fibrosis: a ... – PowerPoint PPT presentation

Number of Views:512
Avg rating:3.0/5.0
Slides: 66
Provided by: nicolem
Category:

less

Transcript and Presenter's Notes

Title: Chronic inflammation and wound healing1 Cellular components


1
Chronic inflammation and wound healing1Cellular
components
  • WWAMI lecture
  • Nicole Meissner-Pearson

2
Outcome of acute inflammation
  • Complete resolution
  • due to elimination of the offending agent and
    regeneration of injured tissue with normal
    function
  • Healing by connective tissue replacement
    (fibrosis/scar formation)
  • Occurs after large tissue destruction,
  • fibrinous exudation into serous cavities
  • tissue without regeneration capabilities
  • Progression to chronic inflammation
  • Resulting in granuloma formation to wall off
    injurious agent and tissue fibrosis (scar
    formation)

3
Definition of chronic inflammation an
inflammatory response of prolonged duration
(weeks months - years) provoked by the
persistence of the causative stimulussimultaneou
s presence of acute inflammation, tissue
destruction and repair
4
Causes of chronic inflammation
  • Infectious organisms that resist clearance and
    form a persistent infection in tissue or
    undrained abscess cavities
  • e.g mycobacterium tuberculosis, actinomycetes,
    treponema palidum and Staph aureus (in bone and
    pleural cavities)
  • Exposure to irritant non-living foreign material
    that can not be removed
  • implanted materials into wounds (wood splinters),
    inhaled materials (silica, asbestos),
    deliberately introduced material (surgical suture
    material or prosthesis)
  • Potentially normal tissue components as seen in
    auto-immune diseases
  • Beta islet cell in diabetes mellitus type I,
    Acetyl cholin receptor in Myastenia gravis

5
Characteristics of chronic inflammation
  • Infiltration of mononuclear cells
  • Tissue destruction
  • Healing with scar formation and fibrosis

6
The dominant cellular player in chronic
inflammation is the tissue macrophage
Blood monocyte
Tissue macrophage (RES)
migrate into tissue within 48 hours after injury
Kupffer cell (liver) Microglia (CNS) Histiocytes
(spleen) Alveolar macs (lung)
and differentiate
It is joined by lymphocytes and plasma cells,
however mast cells and eosinophils are as well
involved in chronic allergic diseases
Plasma cell
Lymphocyte
7
In chronic inflammation macrophage accumulation
persists by different mechanisms
  • Continued recruitment of monocytes from the
    circulation
  • Local proliferation
  • Prolonged survival and immobilization

8
During chronic inflammation macrophages serve to
eliminate injurious agents and initiate repair-
however, they are as well responsible for much of
the tissue injury that occurs
Tissue macrophage
Activated T cell or NK cell
IFN-g
Non Immune activation Endotoxins, fibronectin,
chemical mediators
Activated macrophage
Fibrosis (Scaring) Growth factors involved in
fibroblast proliferation (PDGF,TGFb,FGF) Angiogene
sis factors (FGF,VEGF) Collagen deposition
(IL-13 and TGFb)
Tissue injury Toxic oxygen metabolites Metallo-pro
teases Coagulation factors AA metabolites and NO
9
Outcome of chronic inflammation
  • Ulcers
  • Fistulas
  • Granulomatous diseases
  • Fibrotic diseases (Scaring)
  • and combinations of the above

10
Examples of severe chronic inflammatory diseases
  • Tuberculosis
  • Sarcoidosis
  • Rheumatoid arthritis and other connective tissue
    diseases
  • Inflammatory bowl diseases (Crohns disease,
    ulcerative colitis)
  • Silicosis and other pneumoconioses
  • Peptic ulcer of the duodenum and stomach
  • Liver cirrhosis
  • Bronchial asthma

11
Mechanisms of regeneration, wound healing and
repair
12
Repair of tissue damage can be broadly separated
into two processes
  • Regeneration
  • Restitution of lost tissue
  • Tissue with high proliferative capacity labile
    tissue
  • (e.g hematopoietic cells, epithelial cells of
    skin and gastrointestinal tract regenerate from
    stem cells)
  • Quiescent tissues stable tissue
  • which normally have low levels of
    replication, however can undergo rapid cell
    division when stimulated
  • (e.g parenchymal cells of liver, kidney,
    pancreas mesenchymal cells as lymphocytes,
    fibroblasts, smooth muscle cells, endothelial
    cells)
  • Healing
  • may restore original structures but results in
    collagen deposition and scar formation
  • in tissue where scaffold is disrupted
  • or damage occurs in non dividing permanent
    tissue (e.g central nervous system, skeletal and
    cardiac muscle)

13
Regeneration requires
  • Presence of stem cells for renewal
  • or tissue cells that are capable to divide in
    response to growth factors
  • Intact tissue scaffold

Most of the processes that are referred to as
regeneration in mammalian organs are actually
compensatory growth processes that involve cell
hypertrophy and hyperplasia (e.g liver
regeneration)
14
Stem cells
  • They are undifferentiated cells that do not yet
    have a specific function.
  • They can replicate for a long period of time and
    give rise to differentiated cells.
  • In every cell division one cell retains its self
    renewing capacity while the other cell can
    undergo differentiation (asymmetric replication)

15
Two types of stem cells
  • embryonic stem cells
  • derived from the inner cell mass of a blastocyst
    from in vitro fertilized eggs
  • are pluripotent and can generate all tissues

16
  • adult (somatic) stem cells
  • they are present in small numbers in various
    tissues of the adult body
  • are typically programmed to form different cell
    types of their own tissue and are therefore
    multipotent
  • in tissues with high turn over (hematopoietc
    system, epithelial lining of the gut and skin)
    they are instrumental in renewal
  • although present in a variety of permanent
    non-dividing tissues they are not very active

17
Bone marrow contains two different types of adult
stem cells the hematopoietic stem cell and the
bone marrow stromal cell
18
Potential plasticity of hematopoietic stem cells
19
Hematopoietic stem cell transplantationan
established treatment option for hematological
disorders and cancers
  • Hematopoietic stem cells can be retrieved from
    the peripheral blood or the bone marrow and
    identified by the expression of the CD34 marker
  • 2X106 HSC/KG body weight of recipient are needed
    for a successful autologous HSC transplantation
  • Under steady state conditions the number of CD34
    cells in peripheral blood is 1-5/mm3
  • Mobilization procedures of CD34 stem cells into
    the peripheral blood can be accomplished by
    administration of G-CSF or GM-CSF to the donor
    and can increase the HSC count in the peripheral
    blood 50 fold

20
Repair by Healing(Scarring)
  • Healing is a fibro-proliferative responses that
    patches rather than restores tissue and
    involves the following processes
  • Induction of an inflammatory response to remove
    dead and damaged tissue
  • Proliferation of parenchymal and connective
    tissue cells
  • Angiogenesis (blood vessel formation) and
    formation of granulation tissue
  • Synthesis of ECM proteins and collagen deposition
  • Tissue remodeling
  • Wound contraction
  • Acquisition of wound strength
  • It usually leads to scar formation and does not
    lead to complete restitution of the injured
    tissue

21
Angiogenesis growth of new blood vessels
  • Angiogenesis occurs in the healthy body for
    healing wounds and for restoring blood flow after
    tissue injury
  • Healthy angiogenesis is tightly controlled by a
    serious of on and off switches (Angiogenic
    growth factors versus angiogenesis inhibitors)
  • In many serious diseases the body loses control
    over angiogenesis and angiogenesis-related
    diseases occur when new blood vessels grow
    excessively or insufficiently

22
Cancer
Rheumatoid arthritis
AIDS complications
Excessive
Psoriasis
Blindness
Angiogenesis
Insufficient
Infertility
Stroke
Scleroderma
Heart disease
Ulcers
23
Angiogenesis / Neovascularization is critical to
chronic inflammation and fibrosis, tumor growth
and vascularization of ischemic tissue
Sprouting
24
VEGF and Angiopoietins are the most important
angiogenic factors
25
Anti-VEGF Fab-fragment treatment is used in tumor
therapy as well as wet macular degeneration
Macular degeneration is a group of diseases
characterized by the breakdown of the macular
leading to the loss of central vision. It is the
leading cause of vision loss in patients over the
age of 55 years Wet macular degeneration is
rapidly progressive and accounts for 10 of cases
with age related AMD. Is the result of abnormal
vessel growth beneath the macula resulting in
bleeding. The first currently approved anti-VEGF
drug for vitrial injection is MACUGEN R
(pegaptanib)
26
Role of extracellular matrix in wound healing
and scar formation
  • Extracellular matrix (ECM) is formed by specific
    secreted macromolecules that form a network on
    which cells grow and migrate along
  • ECM is secreted locally and forms a significant
    proportion of the tissue volume
  • ECM sequesters
  • water that provides turgor to soft tissues
  • and minerals that provides rigidity to skeletal
    muscles
  • Forms a reservoir for growth factors
  • ECM proteins assemble into two general
    organizations
  • Interstitial matrix (present between cells)
  • Basement membrane BM (produced by epithelial
    and mesenchymal cells and is closely associated
    with the cell surface)

27
Three groups of macromolecules constitute the ECM
  • Fibrous structural proteins
  • Collagen
  • Fibrillins
  • Adhesive glycoproteins
  • Cadherin
  • Integrins
  • Immunoglobulin family
  • Selectins
  • Proteoglycans and Hyaluronic Acid

28
  • Fibrous structural proteins
  • Collagens
  • Collagens are the most abundant proteins
  • 27 different types
  • Type I,II, III, V and XI are the most abundant
    (interstitial or fibrillar collagens)
  • Provide tensile strength of tissue
  • Fibrillar collagen requires hydroxylation of
    proline and lysine in procollagen which is
    dependent on Vitamin C
  • Type IV is the main component of Basemant
    membrane and forms sheets)
  • Elastins and Fibrillins
  • Provide tissue with the ability to recoil
  • Elastins are found in large vessels, uterus, skin
    and ligaments
  • Fibrillins form a scaffolding for the deposition
    of elastins
  • Marfan syndrome is an inherited autosomal
    dominant defect in fibrillin synthesis. Without
    the structural support provided by fibrillin,
    many tissues are weakened, which can have severe
    consequences, for example, ruptures in the walls
    of major arteries.

29
  • Proteoglycans and hyaluronic acid
  • Proteoglycans (mucoproteins) are formed of
    glucosaminoglycans (GAGs) covalently attached to
    core proteins and are highly negatively charged
  • Biophysical functions due to ability to fill
    space, bind and organize water molecules and
    repel negatively charges molecules
  • They are ideal lubricating fluids in the joint
    due to high viscosity and low compressibility
  • Biochemical functions are mediated by specific
    binding of GAGs to other macromolecules
  • e.g Antithrombin III (AT III) binds tightly to
    heparin and heparan sulfates and inactivates
    factor II, IXa and XIa thus controlling blood
    coagulation
  • Proteoglycans (such as Syndecan) act as
    reservoirs for growth factors secreted into the
    ECM by binding the latter.

30
Chronic inflammation 2Cutaneous wound
healingGranulomatous inflammation
  • Nicole Meissner-Pearson

31
Cutaneous wound healing
  • is generally divided into three overlapping
    phases
  • Inflammation
  • Granulation tissue formation and
    re-epithelialization
  • Wound contraction, extracellular matrix
    deposition and remodeling

32
The phases of cutaneous wound healing
Injury leads to accumulation of platelets and
coagulation factors. Coagulation results in
fibrin formation and release of PDGF and TGF-b
and other inflammatory mediators by activated
platelets. This leads to more Neutrophil
recruitment which signals the beginning of
inflammation (24 h). After 48 h macrophages
replace neutrophils. Neutrophils and macrophages
are responsible for removal of cellular debris
and release growth factors to reorganize the
cellular matrix. At 72 hours the proliferation
phase begins as recruited fibroblasts stimulated
by FGF and TFG-b begin to synthesize collagen.
Previously formed fibrin forms initial matrix for
fibroblasts Collagen cross-linking and
reorganization occurs following months after
injury in the remodeling phase of repair. Wound
contraction follows in large surface wounds and
is facilitated by actin-containing fibroblasts
(myofibroblasts)
33
TGF-b functions as a central regulator of tissue
repair and negatively regulates both acquired and
adaptive immunity
Lack of the TGFb1 gene in mice results in
excessive tissue inflammation and autoimmunity
resulting in death of the animals, however
increased activity leads to excessive scar
formation and loss of organ function
34
Skin wounds are classically described to heal by
eitherprimary or secondary intention and the
distinction is made by the nature and extent of
the wound
  • Healing by first intention
  • wounds with clean opposing edges (surgical
    incision, should form a narrow scar due to small
    amount of granulation tissue required to fill the
    gap)
  • Healing by second intention
  • wounds with separated edges (trauma that requires
    abundance of granulation tissue for wound
    closure)
  • Granulation tissue consists of newly formed blood
    vessels, macrophages, fibroblasts and loose ECM
    framework
  • As collagen accumulation increases, the
    granulation tissue scaffolding is converted into
    a mature scar composed of mature spindle-shaped
    fibroblasts, dense collagen and elastic fibers.
  • The mature scar does not contain vessels

35
Complications of wound healing
  • Deficient scar formation
  • Wound dehiscence
  • Ulceration
  • Excessive formation of scar tissue
  • Keloid (excessive collagen deposition)
  • Exuberant granulation (proliferation of
    fibroblasts that inhibits re-epithelialization)
  • Desmoid (aggressive fibromatosis, semi-malignant)
  • Contraction

36
Wound ulceration
Wound dehiscence
Contracture
Keloid
37
Factors that influence wound healing
  • Systemic factors
  • Malnutrition
  • Protein deficiency
  • Vitamin C deficiency (inhibition of collagen
    synthesis)
  • Metabolic status
  • e.g Diabetes mellitus
  • Consequence of microangiopathy
  • Cortison treatment
  • inhibits inflammation and collagen synthesis
  • Circulatory status
  • Inadequate blood supply due to ateriosclerosis
  • Varicose veins (retarded venous drainage)

38
Factors that influence wound healing (continue)
  • Local Factors
  • Infection (single most important reason for
    delayed wound healing)
  • Foreign bodies
  • suture material, bone and wood splinters .
  • Mechanical factors
  • Early movement
  • Pressure

39
Granulomatous inflammation
Granulomas are millimeter size nodules of chronic
inflammatory cells that can be isolated or
confluent. Granuloma formation is the result of
dealing with indigestible substances or pathogens
and walls them off The essential component are
modified macrophages named epithelioid cell
(because of shape). Epithelioid cells can form
multinucleated giant cells. Epithelioid cells are
surrounded by a collar of lymphocytes and
occasionally plasma cells. Fibrous connective
tissue often surrounds granulomas (remodeling of
tissue) Areas within the granuloma can undergo
necrosis (prototype caseous necrosis in
tuberculosis). Necrosis can lead to calcification
or liquefaction and formation of a cavern if
drained.
40
Examples of granulomatous inflammation
  • Specific infections (immune granuloma)
    Mycobacteria (tuberculosis, lepprosy) syphilis,
    brucellosis,
  • Foreign bodies
  • endogenous
  • ( keratin, necrotic bone or adipose tissue uric
    acid crystals)
  • Exogenous
  • (wood, silica, asbestos, silicone)
  • Specific chemicals
  • Beryllium
  • Drugs
  • Allupurinol, phenylbutazone, sulphonamides (in
    liver)
  • Unknown origin
  • Sarcoidosis
  • (although granuloma typically form to defend the
    host against known injurious agents, they can
    develop for unknown reasons and become injurious
    themselves)
  • Hypersensitivity pneumonitis

Tuberculosis
Foreign body aspiration
Berrylliosis
41
Granuloma a hallmark of tuberulosis
  • Infectious bacilli are inhaled by droplets
  • Infectious dose is estimated by a single
    bacterium
  • Bacteria are phagocytosed by alveolar macrophages
  • A localized inflammatory response recruits more
    mononuclear cells
  • The granuloma consists of a kernel of infected
    macrophages surrounded by foamy macrophages and a
    ring of lymphocytes and a fibrous cuff
    (containment phase)
  • Containment usually fails when the immune status
    of the patient changes the granuloma caseates,
    ruptures and spills into the airway

42
Microscopic and macroscopic appearance of
tuberculosis
Cavity formation due to liquefaction and
drainage of TBC lesion
Characteristic tubercle with caseating necrosis
in center
Macroscopic lesion in TBC
43
Pulmonary Granulomatous inflammationTuberculosis
, Sarcoidosis, hypersensitivity Pneumonitits
Normal lung
Characteristic sarcoid noncaseating granuloma of
the lung with many giant cells
Characteristic tubercle with caseating necrosis
in center
Hypersensitivity Pneumonitits with loosely formed
interstitial granuloma
44
Sarcoidosis versus Hypersensitivity Pneumonitits
  • Sarcoidosis
  • is a systemic disease of unknown origin
    characterized by non-caesating granulomas in many
    tissues
  • 90 of cases have primarily pulmonary
    manifestations
  • Histological diagnosis is made by exclusion
  • Prevalence is higher in women
  • Is 10 X higher in American blacks versus whites
  • Histologically the lesions are distributed
    primarily along lymphatics, around blood vessels
    and
  • The process is driven by CD4-T cells
  • Intra-aveolar and interstitial accumulation of
    CD4-T cells results in CD4CD8 ratios of 51 and
    151
  • Hypersensitivity Pneumonitis (HP)
  • also called extrinsic allergic alveolits
  • HP is caused by sensitization to repeated
    inhalation of dusts containing organic antigens
  • The dust can be derived from a variety of sources
    such as dairy and grain products, animal dander
    and others
  • The most common antigen are thermophilic
    actinomycetes (farmers lung) and avian proteins
    (bird fanciers disease)
  • The disease is immunologically mediated
  • The immune pathogenesis involves macrophages, CD4
    T-cells and particularly CD8 T-cells

45
Pathogenesis of immune Granuloma formation a
result of delayed type hypersensitivity reaction
Alveolar macrophages appear first to come in
contact with the offending agent (e.g are
infected by mycobacteria) Activated macrophages
produce IL-1, TNF-a, IL-12, IL-6 TGF-b and IL-10
and process the antigen Dendritic cells migrate
to the regional lymphnode and activate antigen
specific T-cells, which under the influence of
IL-12 produce IFN-g and further activate
recruited macrophages Release of TNF-a and IL-8
leads to recruitment of neutrophils and monocytes
from the circulation, IL-15 and RANTES leads to
recruitment of T cells. This is followed by the
organization of cells into a tight granuloma and
development of epithelioid cells. Chronic
granulomatous inflammation can result into
connective tissue deposition and fibrosis (tissue
remodeling)
46
Severe pulmonary changes with honey comb like
structures suggesting fibrosis
Bi-hiliar lymphadenopathy and pulmonary
infiltrate in sarcoidosis
47
Mechanisms of fibrosis
  • Nicole Meissner-Pearson

48
Mechanisms of Fibrosisa result of chronic
inflammation and repair
  • Fibrosis
  • excessive accumulation of extracellular-matrix
    components such as collagen that is produced by
    local fibroblasts leading to a permanent fibrotic
    scar
  • Macrophages and fibroblasts are the main effector
    cells involved in the pathogenesis of fibrosis
  • Pro-fibrotic mediators such as TGF-b and IL-13
    amplify this process
  • The degradation of collagen is controlled by
    Matrix-Metallo-proteinases (MMPs) and are
    activated by IFN-g
  • Therefore the net increase of collagen within a
    wound is controlled by the balance of these
    opposing mechanisms
  • Although severe acute injuries can cause marked
    tissue remodeling. Fibrosis that is associated
    with chronic injury (repetitive) is unique in
    that the adaptive immune response is thought to
    have an important role

49
TH-2 cytokines IL-4 and IL-13 lead to
alternative activation of macrophages
  • Macrophages differentiate into at least two
    functionally distinct populations depending on
    whether they are exposed to TH-1 or TH-2
    cytokines
  • TH-1 cytokine activate NOS2 in classically
    activated macrophages whereas TH-2 cytokines IL-4
    and IL-13 preferentially stimulate Arginase-1
    (ARG1) leading to an alternative activation
    pathway
  • ARG1 promotes the generation of polyamines and
    L-proline via metabolism of L-arginine to
    L-ornithine and activation of ODC and OAT
  • Polyamines are crucial for cell growth and
    L-proline is a substrate for collagen synthesis

50
A balance between TH-2 and TH-1 cytokines is
necessary to promote healing but inhibit
excessive fibrotic tissue remodeling
Therapeutics that modulate this balance may be
beneficial in patients suffering from fibrotic
diseases. Drugs that directly inhibit TGF-b1 and
IL-13 might prove the safest and most effective
approach
51
Fibrotic tissue remodeling can result in loss of
organ function
  • Fibrotic changes can occur in various vascular
    diseases including
  • Cardiac diseases
  • Peripheral vascular diseases
  • They affect as well main organ systems like
  • Skin
  • Lung
  • Liver
  • Kidney

52
Tight skin and skin necrosis due to Sclerodermia
Lung fibrosis due to sarcoidosis
53
Liver cirrhosis
Liver cirrhosis macroscopic and microscopic
normal liver histology
54
Liver cirrhosis
  • Cirrhosis represents the common histological
    pathway for a wide variety of liver diseases
  • It is defined histologically as a diffuse hepatic
    process characterized by the presence nodular
    proliferation of hepatocytes surrounded by bands
    of fibrosis

55
Most common causes of liver cirrhosis in the USA
(updated Nov. 2005 Davis C. Wolf, New York
Medical College)
  • Hepatitis C (26)
  • Alcoholic liver disease (21)
  • Hepatitis C plus alcoholic liver disease (15)
  • Cryptogenic causes (18)
  • Hepatitis B (with or without Hepatitis D, 15)
  • Miscellaneous(5)

56
Clinical consequences and signs of liver disease
  • Characteristic signs
  • Jaundice and cholestasis
  • Hypoalbuminemia
  • Hyperammonemia
  • Hypoglycemia
  • Palmar erythema
  • Spider angiomas
  • Hypogonadism
  • Gynecomastia
  • Muscle wasting
  • Portal hypertension due to fibrosis
  • Ascites
  • Splenomegaly
  • Hemorrhoids
  • Caput medusa

57
Jaundice (note yellow sclera and skin)
Spider angioma
Palmar erythema
58
Laboratory evaluation of liver diseases
  • Disruption of Hepatocyte integrity
  • Elevated serum aspartate amino transferase (AST
    sGOT)
  • Elevated serum alanine amino transferase (ALT
    sGPT)
  • Biliary excretory function
  • Elevated total bilirubin (unconjugated and
    conjugated)
  • direct bilirubin conjugated
  • indirect bilirubin unconjugate
  • Plasma membrane enzymes
  • Elevated serum alkaline phosphatase (ALP)
  • Elevated serum g-glutamyl transpetidase (gGT)
  • Hepatocyte function
  • Decreased serum albumin
  • Hypoglycemia
  • Decreased clotting time (early decrease of PT due
    to short half live of factor VII, cholestasis
    results in decreased uptake of vitamin K)
  • Elevated serum ammonia

59
Bilirubin metabolism
  • Bilirubin end product of heme degradation
  • Majority is derived from the break down of
    senescent erythrocytes
  • Heme is oxygenized to biliverdin and reduced to
    bilirubin by phagocytes
  • Bilirubin is virtually water insoluble and needs
    to be bound to albumin to be transported to the
    liver
  • Upon uptake into the liver bilirubin will be
    conjugated with one or two molecules of
    glucuronic acid by bilirubin UDP-glucuronyl
    transferase in the endoplasmatic reticulum
  • Conjugated bilirubin is non toxic, water- soluble
    and is excreted into bile
  • Most bilirubin glucuronides are de- conjugated in
    the intestines to urobilinogen and 20 is
    reabsorbed and promptly excreted via bile

60
Cholestasis and jaundice
  • Hepatic bile formation serves two major
    functions
  • Emulsification of dietary fat (bile acids are
    strong detergents)
  • Elimination of systemic waste products
    (bilirubin, excess cholesterol and other water
    insoluble products)
  • Jaundice is the result of tissue accumulation of
    unconjugated or conjugated bilirubin in tissues.
    It becomes evident when plasma levels exceed
    2mg/dl. Clearance of bilirubin can be disturbed
    by
  • Excessive production (e.g. hemolysis)
  • Reduced hepatocyte uptake (e.g. drugs,
    hepatocellular disease)
  • Impaired conjugation (enzyme defect or
    overwhelmed system)
  • Cholestasis
  • Clinically, Cholestasis is any condition in which
    substances normally excreted into bile are
    retained
  • Increased serum concentrations of conjugated
    bilirubin is the principal sign of cholestasis
  • Conjugated bilirubin is water soluble and is
    secreted in urin (dark urine)
  • Complete cholestasis leads to decoloration of
    feces
  • Cholestasis may present with jaundice and
    pruritus due to deposition of bilirubin and bile
    acids in peripheral tissues

61
Histopathologically Cholestasis is defined by the
appearance of bile within the elements of the
liver
  • Mechanisms of Cholestasis are broadly classified
    into
  • Hepatocellular (impaired bile formation,
    histological appearance of bile within
    hepatocytes feathery degeneration, and
    canalicular spaces leading to hepatocyte injury)
  • Obstructive (impairment of bile flow usually due
    to physical obstruction of bile duct
    extraheaptic stone/tumor bile plugging of the
    interlobular bile ducts, portal expansion and
    bile duct proliferation)
  • Unrelieved obstruction leads to portal tract
    fibrosis and ultimately end-stage bile stained
    cirrhotic liver disease

62
Role of Kupffer cells and Stellate cells in
induction of cirrhosis
63
Portal hypertension increased resistance to
portal vein blood flow
  • Causes
  • Pre-Hepatic
  • Obstructive thrombosis of portal vein
  • Intra-Hepatic
  • Fibrosis
  • Schistosomiasis
  • Granulomatous diseases
  • Post-Hepatic
  • Sever right heart failure
  • Constrictive pericarditis
  • Hepatic vein out flow obstruction

64
Portal hypertension in cirrhosis results from
increased flow resistance at the level of
sinusoids and compression of terminal hepatic
veins by perivenular scaring
The four clinical consequences Ascites Formation
of porto-systemic shunts Congestive
splenomegaly Hepatic Encephalopathy
65
Life threatening complications of chronic liver
disease and fibrosis
  • Hepatic failure leading to
  • Hepatic Encephalopathy (due to ammonemia)
  • Coagulopathy
  • Multiorgan failure
  • Portal hypertension from cirrhosis
  • Esophageal varices with bleeding
  • Ascites with spontaneous peritonitis
  • Hepatocellular carcinoma (very long term)
Write a Comment
User Comments (0)
About PowerShow.com